Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Reexamination Certificate
2006-09-12
2006-09-12
Hayes, Robert C. (Department: 1649)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
C435S368000
Reexamination Certificate
active
07105150
ABSTRACT:
Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
REFERENCES:
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Johe
patent: 5843633 (1998-12-01), Yin et al.
patent: 5851832 (1998-12-01), Weiss et al.
patent: 5968829 (1999-10-01), Carpenter
patent: 6451306 (2002-09-01), Tuszynski et al.
patent: WO 94/02593 (1994-02-01), None
patent: WO 00/12683 (2000-03-01), None
Corbeil et al.,AC133 Hematopoietic Stem Cell Antigen: Human Homologue of Mouse Kidney Prominin or Distinct Member of a Novel Protein Family? 91 BLOOD 2625 (1998).
De Wynter et al.,Characteristics of MACS Isolated CD34+AC133+ Hematopoietic Progenitor Cells, 2 MACS & MORE 8 (1998).
Miraglia et al.,AC133, A New Antigen for Human Hematopoietic Stem Cells. Is Prominin the Murine Homologue? 2 MACS & MORE 6 (1998).
Miraglia et al.,A Novel Five-Transmembrane Hematopoietic Stem Cell Antigen: Isolation, Characterization and Molecular Cloning, 90 BLOOD 5013 (1997).
Miraglia et al.,A Response to AC133 Hematopoietic Stem Cell Antigen: Human Homologue of Mouse Kidney Prominin or Distinct Member of a Novel Protein Family? 91 BLOOD 4390 (1998).
Yin et al.,AC133, A Novel Marker for Human Hematopoietic Stem and Progenitor Cells, 90 BLOOD 5002 (1997).
Uchida et al. Society for Neuroscience Abstracts 25 (1-2): 1767 (1999).
Weigmann et al. Proc. Natl. Acad. Sci. USA 94:12425-12430 (Nov. 11, 1997).
Corbeil et al. Journal of Cell Science, 112:1023-1033 (1999).
Buck David W.
Uchida Nobuko
Weissman Irving
Elrifi, Esq. Ivor R.
Hayes Robert C.
Mintz Levin Cohen Ferris Glovsky and Popeo, P.C.
StemCells California, Inc.
Stock, Esq. Chrisitna K.
LandOfFree
In vivo screening methods using enriched neural stem cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with In vivo screening methods using enriched neural stem cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo screening methods using enriched neural stem cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3547055